213 related articles for article (PubMed ID: 19577248)
21. Myosin light chain kinase knockout improves gut barrier function and confers a survival advantage in polymicrobial sepsis.
Lorentz CA; Liang Z; Meng M; Chen CW; Yoseph BP; Breed ER; Mittal R; Klingensmith NJ; Farris AB; Burd EM; Koval M; Ford ML; Coopersmith CM
Mol Med; 2017 Aug; 23():155-165. PubMed ID: 28598488
[TBL] [Abstract][Full Text] [Related]
22. Glucagon-like peptide 2 attenuates intestinal mucosal barrier injury through the MLCK/pMLC signaling pathway in a piglet model.
Chang Y; Deng Q; Zhang Z; Zhao H; Tang J; Chen X; Liu G; Tian G; Cai J; Jia G
J Cell Physiol; 2021 Apr; 236(4):3015-3032. PubMed ID: 32960454
[TBL] [Abstract][Full Text] [Related]
23. Ethanol impairs intestinal barrier function in humans through mitogen activated protein kinase signaling: a combined in vivo and in vitro approach.
Elamin E; Masclee A; Troost F; Pieters HJ; Keszthelyi D; Aleksa K; Dekker J; Jonkers D
PLoS One; 2014; 9(9):e107421. PubMed ID: 25226407
[TBL] [Abstract][Full Text] [Related]
24. Postinjury vagal nerve stimulation protects against intestinal epithelial barrier breakdown.
Krzyzaniak M; Peterson C; Loomis W; Hageny AM; Wolf P; Reys L; Putnam J; Eliceiri B; Baird A; Bansal V; Coimbra R
J Trauma; 2011 May; 70(5):1168-75; discussion 1175-6. PubMed ID: 21610431
[TBL] [Abstract][Full Text] [Related]
25. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Use of Proton Pump Inhibitors Disrupts Intestinal Tight Junction Barrier and Exaggerates Experimental Colitis.
Nighot M; Liao PL; Morris N; McCarthy D; Dharmaprakash V; Ullah Khan I; Dalessio S; Saha K; Ganapathy AS; Wang A; Ding W; Yochum G; Koltun W; Nighot P; Ma T
J Crohns Colitis; 2023 Apr; 17(4):565-579. PubMed ID: 36322638
[TBL] [Abstract][Full Text] [Related]
27. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
Ye X; Sun M
Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
[TBL] [Abstract][Full Text] [Related]
28. Role of non-muscle myosin light chain kinase in neutrophil-mediated intestinal barrier dysfunction during thermal injury.
Guo M; Yuan SY; Frederich BJ; Sun C; Shen Q; McLean DL; Wu MH
Shock; 2012 Oct; 38(4):436-43. PubMed ID: 22814287
[TBL] [Abstract][Full Text] [Related]
29.
Han J; Li JH; Bai G; Shen GS; Chen J; Liu JN; Wang S; Liu XJ
World J Gastroenterol; 2017 Mar; 23(12):2175-2184. PubMed ID: 28405145
[TBL] [Abstract][Full Text] [Related]
30. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
[TBL] [Abstract][Full Text] [Related]
31. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
[TBL] [Abstract][Full Text] [Related]
32. [Jiawei Baitouweng Decoction affects intestinal mucosal tight junction proteins in rats with ulcerative colitis through p38 MAPK-MLCK signaling pathway].
Zhang PP; Yang X; Liang GQ; Zhu HP; Zhu H; Wang M; Sun HW
Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5719-5726. PubMed ID: 34951226
[TBL] [Abstract][Full Text] [Related]
33. Naringin attenuates MLC phosphorylation and NF-κB activation to protect sepsis-induced intestinal injury via RhoA/ROCK pathway.
Li Z; Gao M; Yang B; Zhang H; Wang K; Liu Z; Xiao X; Yang M
Biomed Pharmacother; 2018 Jul; 103():50-58. PubMed ID: 29635128
[TBL] [Abstract][Full Text] [Related]
34. Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway.
Han B; Sheng B; Zhang Z; Pu A; Yin J; Wang Q; Yang K; Sun L; Yu M; Qiu Y; Xiao W; Yang H
Shock; 2016 Sep; 46(3):319-28. PubMed ID: 26939041
[TBL] [Abstract][Full Text] [Related]
35. Delayed topical p38 MAPK inhibition attenuates full-thickness burn wound inflammatory signaling.
Carter D; Warsen A; Mandell K; Cuschieri J; Maier RV; Arbabi S
J Burn Care Res; 2014; 35(2):e83-92. PubMed ID: 23666384
[TBL] [Abstract][Full Text] [Related]
36. Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression.
Kim MR; Cho SY; Lee HJ; Kim JY; Nguyen UTT; Ha NM; Choi KY; Cha KH; Kim JH; Kim WK; Kang K
Phytomedicine; 2022 Aug; 103():154209. PubMed ID: 35689901
[TBL] [Abstract][Full Text] [Related]
37. OTA induces intestinal epithelial barrier dysfunction and tight junction disruption in IPEC-J2 cells through ROS/Ca
Wang H; Zhai N; Chen Y; Fu C; Huang K
Environ Pollut; 2018 Nov; 242(Pt A):106-112. PubMed ID: 29966834
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of long myosin light-chain kinase activation alleviates intestinal damage after binge ethanol exposure and burn injury.
Zahs A; Bird MD; Ramirez L; Turner JR; Choudhry MA; Kovacs EJ
Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(6):G705-12. PubMed ID: 22790598
[TBL] [Abstract][Full Text] [Related]
39. Lipopolysaccharide-Induced Increase in Intestinal Epithelial Tight Permeability Is Mediated by Toll-Like Receptor 4/Myeloid Differentiation Primary Response 88 (MyD88) Activation of Myosin Light Chain Kinase Expression.
Nighot M; Al-Sadi R; Guo S; Rawat M; Nighot P; Watterson MD; Ma TY
Am J Pathol; 2017 Dec; 187(12):2698-2710. PubMed ID: 29157665
[TBL] [Abstract][Full Text] [Related]
40. Aflatoxin B1 Induces Intestinal Barrier Dysfunction by Regulating the FXR-Mediated MLCK Signaling Pathway in Mice and in IPEC-J2 Cells.
Liu S; Li J; Kang W; Li Y; Ge L; Liu D; Liu Y; Huang K
J Agric Food Chem; 2023 Jan; 71(1):867-876. PubMed ID: 36579420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]